|
1
|
Zhao P, Pan Z, Luo Y, Zhang L, Li X, Zhang G, Zhang Y, Cui R, Sun M, Zhang X. Alantolactone Induces Apoptosis and Cell Cycle Arrest on Lung Squamous Cancer SK-MES-1 Cells. J Biochem Mol Toxicol 2015; 29:199-206. [PMID: 25597476 DOI: 10.1002/jbt.21685] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2014] [Revised: 11/20/2014] [Accepted: 12/10/2014] [Indexed: 12/29/2022]
Affiliation(s)
- Peng Zhao
- Department of Anesthesiology; The Second Hospital of Jilin University; Changchun Jilin 130041 China
| | - Zhenxiang Pan
- Department of Anesthesiology; The Second Hospital of Jilin University; Changchun Jilin 130041 China
| | - Yungang Luo
- Jilin Provincial Key Laboratory on Molecular and Chemical Genetic; The Second Hospital of Jilin University; Changchun Jilin 130041 China
| | - Leilei Zhang
- Department of Anesthesiology; The Second Hospital of Jilin University; Changchun Jilin 130041 China
| | - Xin Li
- Jilin Provincial Key Laboratory on Molecular and Chemical Genetic; The Second Hospital of Jilin University; Changchun Jilin 130041 China
| | - Guangxin Zhang
- Department of Thoracic Surgery; The Second Hospital of Jilin University; Changchun Jilin 130041 China
| | - Yifan Zhang
- Department of Thoracic Surgery; The Second Hospital of Jilin University; Changchun Jilin 130041 China
| | - Ranji Cui
- Jilin Provincial Key Laboratory on Molecular and Chemical Genetic; The Second Hospital of Jilin University; Changchun Jilin 130041 China
| | - Mei Sun
- Department of Pathology; The Second Hospital of Jilin University; Changchun Jilin 130041 China
| | - Xingyi Zhang
- Department of Thoracic Surgery; The Second Hospital of Jilin University; Changchun Jilin 130041 China
| |
Collapse
|
|
2
|
Houzé S, Hoang NT, Lozach O, Le Bras J, Meijer L, Galons H, Demange L. Several human cyclin-dependent kinase inhibitors, structurally related to roscovitine, are new anti-malarial agents. Molecules 2014; 19:15237-57. [PMID: 25251193 PMCID: PMC6271241 DOI: 10.3390/molecules190915237] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2014] [Revised: 09/08/2014] [Accepted: 09/11/2014] [Indexed: 11/16/2022] Open
Abstract
In Africa, malaria kills one child each minute. It is also responsible for about one million deaths worldwide each year. Plasmodium falciparum, is the protozoan responsible for the most lethal form of the disease, with resistance developing against the available anti-malarial drugs. Among newly proposed anti-malaria targets, are the P. falciparum cyclin-dependent kinases (PfCDKs). There are involved in different stages of the protozoan growth and development but share high sequence homology with human cyclin-dependent kinases (CDKs). We previously reported the synthesis of CDKs inhibitors that are structurally-related to (R)-roscovitine, a 2,6,9-trisubstituted purine, and they showed activity against neuronal diseases and cancers. In this report, we describe the synthesis and the characterization of new CDK inhibitors, active in reducing the in vitro growth of P. falciparum (3D7 and 7G8 strains). Six compounds are more potent inhibitors than roscovitine, and three exhibited IC50 values close to 1 µM for both 3D7 and 7G8 strains. Although, such molecules do inhibit P. falciparum growth, they require further studies to improve their selectivity for PfCDKs.
Collapse
Affiliation(s)
- Sandrine Houzé
- Laboratoire de Parasitologie, CNR du Paludisme, AP-HP, Hôpital Bichat & UMR 216 IRD, Université Paris Descartes, Sorbonne Paris Cité, UFR des Sciences Pharmaceutiques, 4 avenue de l'Observatoire, Paris 75006, France.
| | - Nha-Thu Hoang
- Laboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques (LCBPT), UMR 8601 CNRS, Université Paris Descartes, Sorbonne Paris Cité, UFR Biomédicale des Saints Pères, 45 rue des Saints-Pères, Paris 75270, France.
| | - Olivier Lozach
- Protein Phosphorylation and Human Diseases Group, CNRS, USR 3151, Station biologique, Roscoff 29680, France.
| | - Jacques Le Bras
- Laboratoire de Parasitologie, CNR du Paludisme, AP-HP, Hôpital Bichat & UMR 216 IRD, Université Paris Descartes, Sorbonne Paris Cité, UFR des Sciences Pharmaceutiques, 4 avenue de l'Observatoire, Paris 75006, France.
| | - Laurent Meijer
- Protein Phosphorylation and Human Diseases Group, CNRS, USR 3151, Station biologique, Roscoff 29680, France.
| | - Hervé Galons
- ManRos Therapeutics, Hôtel de Recherche, Centre de Perharidy, Roscoff 29680, France.
| | - Luc Demange
- Laboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques (LCBPT), UMR 8601 CNRS, Université Paris Descartes, Sorbonne Paris Cité, UFR Biomédicale des Saints Pères, 45 rue des Saints-Pères, Paris 75270, France.
| |
Collapse
|
|
3
|
Demange L, Abdellah FN, Lozach O, Ferandin Y, Gresh N, Meijer L, Galons H. Potent inhibitors of CDK5 derived from roscovitine: Synthesis, biological evaluation and molecular modelling. Bioorg Med Chem Lett 2013; 23:125-31. [DOI: 10.1016/j.bmcl.2012.10.141] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2012] [Revised: 10/29/2012] [Accepted: 10/31/2012] [Indexed: 01/02/2023]
|